Literature DB >> 26313667

Chronic Infection and Venous Thromboembolic Disease.

Olivier Epaulard1, Alison Foote2, Jean-Luc Bosson2.   

Abstract

Venous thromboembolic disease often arises as a complication of another pathological condition and/or triggering event. Infectious diseases result from both the direct action of the pathogens themselves and their effect on the immune system. The resulting inflammatory process and the coagulation and fibrinolysis processes share common pathways, explaining why infection is associated with thrombosis. In this brief overview, besides certain chronic infectious diseases, we also consider some acute infections, as the mechanisms are likely to be similar, particularly in the initial infective stage or the more acute episodes of a chronic infection. The infectious agent can be viral, bacterial, fungal, or parasitic. However, the literature on the link between infections and venous thromboembolism (VTE) is uneven, favoring infections that are found in more developed countries where physicians have access to VTE diagnostic tools. Thus, large epidemiological studies in this field are restricted to a limited number of the common chronic infectious diseases such as tuberculosis, while for other infections, particularly parasitic and fungal infections, the link with VTE is only evoked in a few scattered case reports. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26313667     DOI: 10.1055/s-0035-1556729

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  11 in total

1.  Hospitalization with infection and incident venous thromboembolism: The ARIC study.

Authors:  Logan T Cowan; Pamela L Lutsey; James S Pankow; Mary Cushman; Aaron R Folsom
Journal:  Thromb Res       Date:  2017-01-25       Impact factor: 3.944

2.  Fatal Pulmonary Embolism in the Setting of Immune Reconstitution Inflammatory Syndrome Attributed to Ovarian Tuberculosis.

Authors:  Israel Ugalde; Daniela Pirela; Saberio Lo Presti; Molly Bilderback; Andrés Pirela; Joseph Chan
Journal:  J Investig Med High Impact Case Rep       Date:  2017-09-08

3.  Anatomic and clinical risk factors for pulmonary embolism in patients with deep venous thrombosis of the lower extremity.

Authors:  Bomina Paik; Jin Hyun Joh; Ho-Chul Park
Journal:  Ann Surg Treat Res       Date:  2017-04-27       Impact factor: 1.859

4.  Coccidioidomycosis and Pulmonary Emboli: A Report of 5 Cases.

Authors:  John G Prichard; Michelle B Azimov; Karlos Z Oregel
Journal:  Am J Case Rep       Date:  2020-07-05

5.  Inpatient and Outpatient Infection as a Trigger of Cardiovascular Disease: The ARIC Study.

Authors:  Logan T Cowan; Pamela L Lutsey; James S Pankow; Kunihiro Matsushita; Junichi Ishigami; Kamakshi Lakshminarayan
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

6.  Epidemiology of venous thromboembolism in people with active tuberculosis: a systematic review and meta-analysis protocol.

Authors:  Philippe Armel Awana; Celestin Danwang; Joel Noutakdie Tochie; Jean Joel Bigna
Journal:  BMJ Open       Date:  2019-11-12       Impact factor: 2.692

Review 7.  Good Fences Make Good Neighbors: Human Immunodeficiency Virus and Vascular Disease.

Authors:  Elizabeth S Mayne; Susan Louw
Journal:  Open Forum Infect Dis       Date:  2019-06-25       Impact factor: 3.835

8.  Thromboses in tuberculosis are linked to antiphosphatidylethanolamine antibodies levels: A cross-sectional study.

Authors:  Simon Bessis; Daniel Bertin; Matthieu Million; Line Meddeb; Michel Drancourt; Jean-Christophe Lagier; Jean-Louis Mège; Nathalie Bardin; Philippe Brouqui
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-02-15

9.  The Assessment of Thromboembolism Risk in Postbariatric Patient: Our Experience in 936 Patients.

Authors:  Giuseppe Tanzillo; Vincenzo Vindigni; Franco Bassetto
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-03-18

10.  Trends in pulmonary embolism in patients infected with HIV during the combination antiretroviral therapy era in Spain: A nationwide population-based study.

Authors:  Alejandro Alvaro-Meca; Pablo Ryan; Dariela Micheloud; Angel De Miguel; Juan Berenguer; Salvador Resino
Journal:  Sci Rep       Date:  2018-08-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.